Invention Grant
- Patent Title: Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
-
Application No.: US15852995Application Date: 2017-12-22
-
Publication No.: US10280157B2Publication Date: 2019-05-07
- Inventor: Ming Tao , William Frietze , David J. Meloni , Lingkai Weng , Jiacheng Zhou , Yongchun Pan
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D271/04 ; C07D271/08 ; C07C307/06
Abstract:
The present application is directed to processes and intermediates for making 4-({2-[(aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N′-hydroxy-1,2,5-oxadiazole-3-carboximidamide, which is an inhibitor of indoleamine 2,3-dioxygenase, useful in the treatment of cancer and other disorders.
Public/Granted literature
- US20180244663A1 PROCESS FOR THE SYNTHESIS OF AN INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR Public/Granted day:2018-08-30
Information query
